Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study

Cancer

Volumn 123, Issue , 2017, Pages 5119-5137

  Benard, Vicki B ^a   Watson, Meg ^a   Saraiya, Mona ^a   Harewood, Rhea ^b   Townsend, Julie S ^a   Stroup, Antoinette M ^c,d   Weir, Hannah K ^a   Allemani, Claudia ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

cervical neoplasms; population based survival; prevention and control; trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLACK PERSON; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; LIFE TABLE; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL TIME; TUMOR INVASION; UNITED STATES; UTERINE CERVIX CANCER; VERY ELDERLY; AFRICAN AMERICAN; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 85037638312     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30906     Document Type: Article

References (32)

1. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2012. http://seer.cancer.gov/csr/1975_2012. Accessed April 2015.
2. Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M. Vital signs: cervical cancer incidence, mortality, and screening—United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014;63:1004-1009.
3. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97:675-683.
4. Wright JD, Chen L, Tergas AI, et al. Population-level trends in relative survival for cervical cancer. Am J Obstet Gynecol. 2015;213:670.e1-670.e7.
5. Sheppard CS, El-Zein M, Ramanakumar AV, Ferenczy A, Franco EL. Assessment of mediators of racial disparities in cervical cancer survival in the United States. Int J Cancer. 2016;138:2622-2630.
6. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977-1010.
7. White MC, Babcock F, Hayes NS, et al. The history and use of cancer registry data by public health cancer control programs in the United States. Cancer. 2017;123:4969-4976.
8. Allemani C, Harewood R, Johnson C, et al. Population-based cancer survival in the United States: data, quality control, and statistical methods. Cancer. 2017;123:4982-4993.
9. Fritz AG, Percy C, Jack A. International Classification of Disease Oncology (ICD-0). Geneva, Switzerland: World Health Organization; 2000.
10. Young JL, Roffers SD, Ries LAD, Fritz AG, Hurlbut AA. SEER Summary Staging Manual–2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute; 2001.
11. Surveillance, Epidemiology, and End Results Program. Collaborative stage. http://seer.cancer.gov/tools/collabstaging. Accessed April, 2016.
12. Spika D, Bannon F, Bonaventure A, et al. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods. BMC Cancer. 2017;17:159.
13. Perme MP, Stare J, Esteve J. On estimation in relative survival. Biometrics. 2012;68:113-120.
14. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307-2316.
15. Quaresma M, Coleman MP, Rachet B. Funnel plots for population-based cancer survival: principles, methods and applications. Stat Med. 2014;33:1070-1080.
16. Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880-891.
17. Benard VB, Eheman CR, Lawson HW, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol. 2004;103:564-571.
18. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63:1-30.
19. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107:djv086.
20. Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300-304.
21. Burger EA, Lee K, Saraiya M, et al. Racial and ethnic disparities in human papillomavirus–associated cancer burden with first-generation and second-generation human papillomavirus vaccines. Cancer. 2016;122:2057-2066.
22. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:850-858.
23. Saraiya M, Watson M, Benard VB. Cervical cancer screening measures need to evolve to continue to tell the story. J Womens Health (Larchmt). 2012;21:1128-1129.
24. Pfaendler KS, Tewari KS. Changing paradigms in the systemic treatment of advanced cervical cancer. Am J Obstet Gynecol. 2016;214:22-30.
25. Ramondetta LM, Meyer LA, Schmeler KM, et al. Avoidable tragedies: disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015;139:500-505.
26. Lantz PM, Mullen J. The National Breast and Cervical Cancer Early Detection Program: 25 years of public health service to low-income women. Cancer Causes Control. 2015;26:653-656.
27. Tangka FK, Howard DH, Royalty J, et al. Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012. Cancer Causes Control. 2015;26:671-686.
28. Ekwueme DU, Uzunangelov VJ, Hoerger TJ, et al. Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007. Am J Prev Med. 2014;47:300-308.
29. National Comprehensive Cancer Control Program. Consortium of national networks to impact tobacco-related and cancer health disparities. http://www.cdc.gov/cancer/ncccp/dp13-1314.htm. Accessed April, 2016.
30. Nuestras Voces. http://www.nuestrasvoces.org/. Accessed April, 2016.
31. Weir HK, Stewart S, Allemani C, et al. Population-based cancer survival (2001-2009) in the United States: findings from the CONCORD-2 study. Cancer. 2017;123:4963-4968.
32. Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;2014:187-197.